Inoue Ken-Ichiro, Takano Hirohisa, Yanagisawa Rie, Hirano Seishiro, Sakurai Miho, Shimada Akinori, Yoshikawa Toshikazu
Environmental Health Sciences Division, National Institute for Environmental Studies, Tsukuba, Japan.
Environ Health Perspect. 2006 Sep;114(9):1325-30. doi: 10.1289/ehp.8903.
Although adverse health effects of particulate matter with a diameter of < 100 nm (nanoparticles) have been proposed, molecular and/or experimental evidence for their facilitation of lung inflammation in vivo is not fully defined.
In the present study we investigated the effects of nanoparticles on lung inflammation related to bacterial endotoxin [lipopolysaccharide (LPS) ] in mice.
We intratracheally administered vehicle, two sizes (14 nm, 56 nm) of carbon black nanoparticles (4 mg/kg) , LPS (2.5 mg/kg) , or LPS plus nanoparticles and evaluated parameters for lung inflammation and coagulation. Nanoparticles alone induced slight lung inflammation and significant pulmonary edema compared with vehicle. Fourteen-nanometer nanoparticles intensively aggravated LPS-elicited lung inflammation and pulmonary edema that was concomitant with the enhanced lung expression of interleukin-1beta (IL-1beta) , macrophage inflammatory protein-1alpha (MIP-1alpha) , macrophage chemoattractant protein-1, MIP-2, and keratinocyte chemoattractant in overall trend, whereas 56-nm nanoparticles did not show apparent effects. Immunoreactivity for 8-hydroxyguanosine, a marker for oxidative stress, was more intense in the lungs from the LPS + 14-nm nanoparticle group than in those from the LPS group. Circulatory fibrinogen levels were higher in the LPS + plus 14-nm nanoparticle group than in the LPS group.
Taken together, evidence indicates that nanoparticles can aggravate lung inflammation related to bacterial endotoxin, which is more prominent with smaller particles. The enhancement may be mediated, at least partly, via the increased local expression of proinflammatory cytokines and via the oxidative stress. Furthermore, nanoparticles can promote coagulatory disturbance accompanied by lung inflammation.
尽管已有人提出直径小于100纳米的颗粒物(纳米颗粒)对健康有不良影响,但关于其在体内促进肺部炎症的分子和/或实验证据尚未完全明确。
在本研究中,我们调查了纳米颗粒对小鼠体内与细菌内毒素[脂多糖(LPS)]相关的肺部炎症的影响。
我们经气管内给予溶剂、两种尺寸(14纳米、56纳米)的炭黑纳米颗粒(4毫克/千克)、LPS(2.5毫克/千克)或LPS加纳米颗粒,并评估肺部炎症和凝血参数。与溶剂相比,单独的纳米颗粒可引起轻微的肺部炎症和显著的肺水肿。14纳米的纳米颗粒在总体趋势上强烈加重了LPS引发的肺部炎症和肺水肿,同时伴有肺部白细胞介素-1β(IL-1β)、巨噬细胞炎性蛋白-1α(MIP-1α)、巨噬细胞趋化蛋白-1、MIP-2和角质形成细胞趋化因子表达增强,而56纳米的纳米颗粒未显示出明显影响。氧化应激标志物8-羟基鸟苷的免疫反应性在LPS + 14纳米纳米颗粒组的肺中比在LPS组的肺中更强。LPS + 14纳米纳米颗粒组的循环纤维蛋白原水平高于LPS组。
综上所述,有证据表明纳米颗粒可加重与细菌内毒素相关的肺部炎症,较小颗粒的这种作用更明显。这种增强可能至少部分是通过促炎细胞因子的局部表达增加和氧化应激介导的。此外,纳米颗粒可促进伴随肺部炎症的凝血紊乱。